BRD4 and non-small cell lung carcinoma: Mechanically, inhibition of BRD4 sensitized NSCLC cells to osimertinib by blocking YAP1-mediated APT1 transcription and disrupting APT1-mediated depalmitoylation of MST1 and YAP1 nuclear translocation.